Is Autoimmune Thrombocytopenia Itself the Primary Disease in the Presence of Second Diseases? Data from a Long-Term Observation

Publisher： Karger

E-ISSN： 1660-3818|44|1|23-28

ISSN： 1660-3796

Source： Transfusion Medicine and Hemotherapy, Vol.44, Iss.1, 2016-10, pp. : 23-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-term treatment of patients with Alzheimer's disease in primary and secondary care: results from an international survey

By Froelich Lutz   Andreasen Niels   Tsolaki Magda   Foucher Arnaud   Kavanagh Shane     Schwalen Susanne  

Current Medical Research and Opinion, Vol. 25, Iss. 12, 2009-12 ,pp. : 3059-3068

Informa Healthcare

Access to resources Recommend Favorite

Rituximab in Previously Treated Primary Immune Thrombocytopenia Patients: Evaluation of Short- and Long-Term Efficacy and Safety

By  

Acta Haematologica, Vol. 132, Iss. 1, 2013-12 ,pp. : 24-29

Karger

Access to resources Recommend Favorite

Gradual thrombocytopenia induced by long‐term trastuzumab exposure

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 41, Iss. 5, 2016-10 ,pp. : 563-565

John Wiley & Sons Inc

Access to resources Recommend Favorite

Velaglucerase alfa (VPRIV) enzyme replacement therapy in patients with Gaucher disease: Long‐term data from phase III clinical trials

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 7, 2015-07 ,pp. : 584-591

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Data from the Swiss Pulmonary Hypertension Registry

By  

Respiration, Vol. 89, Iss. 2, 2015-01 ,pp. : 127-140

Karger

Access to resources Recommend Favorite